CLINICAL_TRIALS
trial_result
· 2026-04-27
Clinical Trial Update: A Study Evaluating TRIV-509 in Atopic Dermatitis [Phase 2]
Summary
Phase 2 clinical trial update for TRIV-509 in atopic dermatitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Triveni Bio | Conditions: Atopic Dermatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING